Overview: Covers background and basic science, erythropoiesis-stimulating agents, chapters on the erythropoietin receptor as well as clinical uses of recombinant erythropoietins.Also of interest to clinicians iResearch on, and interest in, red blood cell formation spans several centuries and was thought to have peaked in the 1980s with the cloning of the eryth- poietin (EPO) gene. In the years subsequent to the cloning of EPO and its expression as a recombinant protein, much was written about EPO. Although much has been learned and published, new, exciting data are becoming ava- able on almost
|